Cannabis/Cannabinoids
How Do Cannabinoid Receptors Affect Motivation to Eat or Exercise?
Physical inactivity is a common factor in lifestyle diseases – and one that is often linked to the excessive consumption of fatty and/or sugary foods. The opposite scenario of excessive physical activity at the expense of caloric intake can also be harmful, as cases of anorexia nervosa illustrate. These scenariosRead
The Endocannabinoid System and the Gut
“The brain and the gut speak the same language” (1) Ethan Russo, MD, Renown Cannabinoid Scientist The endocannabinoid system (ECS) is a network of receptors and enzymes that are spread throughout the body. This system can interact with one’s own cannabinoids (endogenous or endocannabinoids) because of substances found in natureRead
Omega-3 Fatty Acids Reduce Inflammation through Cannabinoids
The chemical compounds called cannabinoids, found in cannabis and hemp, are also produced naturally in the body from omega-3 fatty acids. A new study in animal tissue reveals the cascade of chemical reactions that convert omega-3 fatty acids into cannabinoids that have anti-inflammatory benefits. The findings are published in theRead
Is the New York Times Picking on the Science for CBD?
A recent New York Times article, CBD is Everywhere, But Scientists Still Don’t Know Much About It, paints a picture of snake-oil sales, hyped-up claims and minuscule science. Is that true or a journalistic stretch? The article prompted Today’s Practitioner to dig up two well-researched studies from Cannabis and CannabinoidRead
Cannabidiol May Reduce Intestinal Inflammation
In this study, published in PLOS ONE, researchers explored the role of cannabidiol for intestinal inflammation. This research looked enteric glial cells (EGC), which plays a fundamental role in the maintenance of gut homeostasis. They assure the correct trophism of vicinal neurons in the myenteric plexus and actively participate inRead
The Endocannabinoid System and Potential Therapeutic Uses in Multiple Sclerosis and other Neuroinflammatory Diseases
Understanding Cannabinoid Delivery Systems and Clinical Applications
Effectiveness of Prescription CBD for Epilepsy May Wane in a Quarter of Patients
Approximately 25 percent of drug-resistant epilepsy patients taking cannabidiol (CBD) developed a tolerance to the treatment, researchers said at the American Epilepsy Society annual meeting taking place Nov.30 – Dec. 4, 2018. The findings suggest that that the effectiveness of the CBD drug might wane in the long term forRead
Is Cannabidiol the Next Clinical Antioxidant?
Emerging research shows that cannabidiol holds unique properties as an antioxidant. In the scientific summary, we profile two studies that review the potential of non-psychotropic cannabidiol as an antioxidant. This research has future clinical implications for cerebral ischemia, rheumatoid arthritis, types I and II diabetes, atherosclerosis, Alzheimer’s disease, hypertension, theRead
Derrick DeSilva, MD, on CBD for Common Conditions, Choosing a Safe, Reliable Brand
In this video, Dr. DeSilva shares some case studies and how he is prescribing CBD for common conditions for his patients. In this video series he discusses the following: Case studies of patient response to CBD for sleep and auto-immunity, Researching the right brand of CBD, What to look forRead
